-
Forward Look
Cancer Screening: A Dose of RealityQ&A with H. Gilbert Welch, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.
by Sue Rochman
-
Forward Look
When Is “Cancer” Not Cancer?Does the word “cancer” discourage patients with very early disease from fully considering all their options?
by Stephen Ornes
-
Forward Look
The Avastin Roller CoasterUps and downs keep coming for Avastin as studies report on its effects for different cancers.
by Sue Rochman
-
Clinical Trials Game-Changer?A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?
by Sue Rochman
-
Cancer In America
Standard of CareResearch suggests that black patients, as a whole, aren't receiving the same level of treatment as white patients. Can building better bonds between doctors and patients help?
by Charlotte Huff
-
The HPV Cancer Connection: Take 2New insights about HPV's role in multiple cancers are rapidly expanding, as are thoughts about who should be vaccinated against the virus, and why.
by Alanna Kennedy-Gorman
-
Healthy Habits
Just Another Meatless MondayMake room for tasty vegetarian dishes in your weekly menu.
by Alanna Kennedy-Gorman
-
Forward Look
Boosting Defenses Against CancerQ&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.
by Ingfei Chen
-
Forward Look
Second-Cancer Clues?Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.
by Mitzi Baker
-
Forward Look
A Burning Question for SmokersIs the considerable risk-reduction benefit of CT screening worth the potential downsides?
by Sue Rochman
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
